Q3 2025 · 13F-HR
MPM ASSET MANAGEMENT LLCholdings as filed
Filed 2025-11-14 · accession 0001193125-25-283116
$44.5M
Reported value
4
Positions
2025-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 29384C108 | TRDA | Entrada Therapeutics, Inc. | $25.4M | 57.1% | 4,381,062 | Common | SOLE |
| 26818M108 | DYN | Dyne Therapeutics, Inc. | $8.6M | 19.4% | 682,376 | Common | SOLE |
| 95075A107 | HOWL | Werewolf Therapeutics, Inc. | $8.5M | 19.1% | 4,309,860 | Common | SOLE |
| 760273102 | RPTX | Repare Therapeutics, Inc. | $2.0M | 4.43% | 1,121,318 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.